# Zhejiang Hisun Pharmaceutical Co., Ltd., Taizhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/zhejiang-hisun-pharmaceutical-co-ltd/38a26f64-d8df-4781-8322-3606f62da25d

> Inspection records and compliance data for Zhejiang Hisun Pharmaceutical Co., Ltd. in Taizhou. 12 FDA inspections on record (1 OAI), 2 Form 483s, 1 warning letter, last inspected June 21, 2024.

---

## Details

- Name: Zhejiang Hisun Pharmaceutical Co., Ltd.
- FEI Number: 3007719313
- Facility Type: API/Finished Drug Product Manufacturer
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: 46 Waisha Rd., Jiaojiang District
- City: Taizhou
- Country Name: China
- Address: 46 Waisha Rd., Jiaojiang District, Taizhou, China
- Country: China

## Related Documents

- FDA Inspection 1238621 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2024-06-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2024
- [EMA GMP - Zhejiang Hisun Pharmaceutical Co., Ltd. - INS/GMP/2018/111; INS/GMP/2018/112; INS/GMP/2019/063 and INS/GMP/2019/064 - 2022-04-19](https://www.keypedia.com/records/ema/zhejiang-hisun-pharmaceutical-co-ltd/af958589-e931-44bd-9f0d-7851c5e1d6d3) — source: EMA, date: April 19, 2022
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/43ac2a52-29ad-4d11-b102-c322a0e8e66b) — source: FDA, date: June 7, 2019
- [FDA Inspection 1096299 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2019-06-07](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/173f8cb1-f958-4ffe-ae3c-9ff0d8830ef2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 7, 2019
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/79173a11-bcaa-4b81-8e6b-2662fd1b9d1a) — source: FDA, date: August 11, 2017
- FDA Inspection 1027076 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-08-07](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/782a5325-2b6a-4fd5-a558-9bd88056c204) — source: FDA, date: August 7, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/5bce805f-5cef-44fe-bc93-6f7b46060574) — source: FDA, date: January 19, 2017
- [FDA Inspection 998186 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-19](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/298ff408-5db4-463e-a0f2-e1b4d261a186) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2017
- [483 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2017-01-16](https://www.keypedia.com/records/483/zhejiang-hisun-pharmaceutical-co-ltd/52384d3b-e571-4eb3-93bb-9eb3742f8b98) — source: FDA, date: January 16, 2017
- [WARNING_LETTER - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.keypedia.com/records/warning_letter/zhejiang-hisun-pharmaceutical-co-ltd/1c80aaa0-7c21-48ef-8a73-80a5561a3e9f) — source: FDA, date: March 7, 2015
- [FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07](https://www.keypedia.com/records/fda_inspections/zhejiang-hisun-pharmaceutical-co-ltd/7d5d3246-ba28-4a79-aae1-fbd352e18a7f) — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- FDA Inspection 918008 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2015-03-07 — classification: Official Action Indicated (OAI), source: FDA, date: March 7, 2015
- FDA Inspection 794531 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19 — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19 — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- FDA Inspection 794437 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19 — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012
- FDA Inspection 793692 - Zhejiang Hisun Pharmaceutical Co., Ltd. - 2012-07-19 — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2012

## Related Companies

- [NATCO Pharma Limited Chemical Division Chennai](https://www.keypedia.com/companies/natco-pharma-limited-chemical-division-chennai/c2978c98-d900-4777-9b55-7c62f09edfe0)
- [Vamsi Labs Ltd](https://www.keypedia.com/companies/vamsi-labs-ltd/6beaf68e-e00d-4385-ac91-70edabcfce9b)
- [Andhra Organics Limited](https://www.keypedia.com/companies/andhra-organics-limited/57dd3443-47f0-4e8d-9940-c4f7e9c61e08)
- [Hikal Limited](https://www.keypedia.com/companies/hikal-limited/cb3e9445-04eb-4d52-af78-793b43f9d61f)
- [Veranova LP](https://www.keypedia.com/companies/veranova-lp/22f7ea09-da55-4ee1-aa40-fce66fa3ef61)
- [Union Carbide Corporation](https://www.keypedia.com/companies/union-carbide-corporation/fa8b4f2e-e47c-4e36-995c-107388af99a5)
- [BioChem Sioux City Inc.](https://www.keypedia.com/companies/biochem-sioux-city-inc/5ce2b95e-6c89-4fb9-bbb4-210bd8272365)
- [Exxonmobil Product Solutions Company](https://www.keypedia.com/companies/exxonmobil-product-solutions-company/8e83c4a4-cc31-4bfd-abc9-d6f2df29259f)
- [VUAB Pharma a.s.](https://www.keypedia.com/companies/vuab-pharma-as/6caae203-57d0-4a6f-b2b8-340c40ec5135)
- [Fukuzyu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de)

## Related Officers

- [Thomas J. Cosgrove](https://www.keypedia.com/people/thomas-j-cosgrove/616abec3-5ed9-42aa-9f5d-392b5552b695)
- [Lindsey M. Schwaigerjohann](https://www.keypedia.com/people/lindsey-m-schwaigerjohann/9cff2b61-0816-4d65-b90f-ed9c892b76f4)
- [President](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)
- [Investigator ](https://www.keypedia.com/people/lindsey-schwierjohann/3608e7c0-5bb9-49f0-844d-ddd6f6724fdb)
